[144] Helmerich & Payne, Inc. SEC Filing

Rhea-AI Filing Summary

Helmerich & Payne, Inc. filed a Form 144 reporting an intended sale of 6,700 common shares via Fidelity Brokerage Services, with an aggregate market value of $119,461 and an approximate sale date of 08/18/2025 on the NYSE. The filing shows the shares were acquired through restricted stock vesting on multiple dates between 12/11/2021 and 01/11/2024 as part of compensation, totaling disclosed lots of 8 separate vesting events. No securities were reported sold in the past three months. The filer certifies they have no undisclosed material information and includes the standard signature and legal notice.

Positive

• Full disclosure of intended sale details including broker, number of shares, aggregate market value, and approximate sale date
• Securities originated from restricted stock vesting and are identified as compensation, clarifying the source of shares
• No securities sold by the filer in the past three months, as reported

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for vested compensation, immaterial relative to outstanding shares.

The Form 144 documents an intended sale of 6,700 shares valued at $119,461, originating from restricted stock vesting events between 2021 and 2024. Given the issuer's reported outstanding share count of 99,439,833, the block represents roughly 0.0067% of outstanding shares, indicating this is a routine monetization of compensation rather than a material disposition. The filing contains required attestations and shows no other sales in the prior three months, supporting a classification of limited investor impact.

Corporate Governance Specialist

TL;DR: Disclosure complies with Rule 144 requirements; transaction stems from compensation vesting.

The notice appropriately details acquisition dates, nature of acquisition (restricted stock vesting), payment as compensation, broker information, and the aggregate market value. The filer affirms absence of undisclosed material information. From a governance perspective, the filing demonstrates standard insider disclosure practices; there is no evidence in this document of unusual timing or concentration of sales that would raise compliance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6700	119461.00	99439833	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/11/2021	Restricted Stock Vesting	Issuer			811	12/11/2021	Compensation
Common	12/14/2021	Restricted Stock Vesting	Issuer			349	12/14/2021	Compensation
Common	11/04/2023	Restricted Stock Vesting	Issuer			222	11/04/2023	Compensation
Common	12/09/2023	Restricted Stock Vesting	Issuer			541	12/09/2023	Compensation
Common	12/10/2023	Restricted Stock Vesting	Issuer			789	12/10/2023	Compensation
Common	12/11/2023	Restricted Stock Vesting	Issuer			933	12/11/2023	Compensation
Common	01/11/2024	Restricted Stock Vesting	Issuer			3055	01/11/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Helmerich & Payne's (HP) Form 144 report?

The filing reports an intended sale of 6,700 common shares with an aggregate market value of $119,461, expected around 08/18/2025 on the NYSE.

Where did the shares being sold by HP come from?

The shares were acquired through restricted stock vesting on multiple dates between 12/11/2021 and 01/11/2024 and were issued as compensation.

Which broker is handling the planned sale in HP's Form 144?

The broker named is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Has the filer sold HP securities in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

How large is the intended sale relative to HP's outstanding shares?

The filing lists 99,439,833 shares outstanding; the 6,700-share block represents roughly 0.0067% of that total.